Universal Health Realty Income Trust Financial Ratios — UHT

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	44.15	10.63	7.67	27.85	11.86	8.91	22.71	11.83	9.97	11.41	55.37	9.09	7.16	10.11	10.61
Return on Assets (%)	25.14	5.17	3.48	12.86	5.34	3.5	8.99	4.97	3.9	3.96	19.99	3.5	2.56	3.27	3.07
Return on Capital (%)	26.42	7.37	5.57	15.3	7.38	5.57	11.43	7.31	6.38	5.98	22.72	5.5	5.6	7.62	7.06
Return on Invested Capital (%)	5.06	4.61	5.06	4.97	4.83	4.75	4.96	5.76	5.57	5.61	5.56	5.29	5.43	6.51	6.34
Gross Margin (%)	93.19	96.07	95.64	95.74	95.61	95.14	95.06	95.01	94.85	94.69	94.77	94.38	94.43	94.46	94.36
EBITDA Margin (%)	74.27	69.06	69.26	67.66	67.36	68.05	68.05	67.53	66.64	65.89	66.71	62.98	61.67	64.68	63.97
Operating Margin (%)	49.5	31.58	34.54	32.57	32.65	33.75	33.37	35.04	33.37	33.33	34.29	33.84	32.8	37.16	35.05
Incremental Operating Margin (%)	-113.96	9.98	517.88	13.17	33.77	56.28	28.52	66.31	-100.21	29.99	46.29	27.99	13.8	158.53	-1,135.75
Pretax Margin (%)	250.2	36.1	24.26	86.23	37.05	25.66	63.05	31.75	24.58	24.93	129.67	23.28	16.11	19.43	17.75
Profit Margin (%)	250.2	36.1	24.26	86.23	37.05	25.66	63.05	31.75	24.58	24.93	129.67	23.28	16.11	19.43	17.75
Net Income to Common Margin (%)	250.2	36.1	24.26	86.23	37.05	25.66	63.05	31.75	24.58	24.93	129.67	23.28	16.11	19.43	17.75
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	41.61	160.16	241.1	63.47	143.89	204.11	79.03	152.22	197.27	195.26	35.3	185.66	258.21	210.01	232.99
Sustainable Growth Rate (%)	25.78	-6.39	-10.83	10.17	-5.2	-9.28	4.76	-6.18	-9.7	-10.87	35.82	-7.78	-11.33	-11.12	-14.11

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	175	198	200	213	252	316	256	261	283	304	340	354	370	379	386
ST Debt	77	82	94	90	142	202	181	196	213	236	272	298	327	349	356
LT Debt	98	116	106	123	110	114	75	65	70	68	68	56	44	30	30
Total Debt/EBITDA	7.98	5.31	5.32	5.27	5.86	6.92	5.21	5.08	5.5	5.91	6.06	6.21	6.28	5.92	6.08
Net Debt/EBITDA	7.45	5.23	5.23	5.17	5.77	6.83	5.14	4.98	5.2	5.63	5.45	5.87	5.96	5.64	5.8
Total Debt/EBIT	11.98	11.62	10.67	10.95	12.08	13.94	10.62	9.78	10.98	11.69	11.79	11.55	11.82	10.3	11.1
Net Debt/EBIT	11.18	11.44	10.49	10.75	11.9	13.77	10.48	9.6	10.39	11.13	10.61	10.93	11.2	9.81	10.58
EBITDA to Interest Expense	9.12	4.8	5.03	4.83	5.24	4.88	4.89	5.32	4.88	6.22	6.38	5.31	3.48	2.69	3.01
EBITDA-CapEx/Interest Expense	-7.62	2.53	4.41	2.97	3.2	-1.58	3.99	4.9	4.4	5.95	4.9	4.04	3.03	2.69	3.01
EBIT to Interest Expense	6.08	2.19	2.51	2.32	2.54	2.42	2.4	2.76	2.44	3.15	3.28	2.85	1.85	1.54	1.65
Interest Expense	2	8	7	8	8	9	10	10	11	8	9	11	17	24	21
Common Equity/Total Assets	50.92	46.38	44.39	47.7	42.54	36.45	42.97	41.06	37.18	32.19	39.32	37.71	33.69	30.91	26.98
Long-Term Debt/Equity (%)	51.7	65.37	64.17	60.32	56.48	59.71	35.79	32.67	38.35	42.65	29.05	24.52	21.8	16.86	19.58
Long-Term Debt/Capital (%)	26.85	30.93	29.07	29.54	24.62	22.53	16.14	14.11	15.01	14.65	11.88	9.63	7.67	5.42	5.54
Long-Term Debt/Total Assets (%)	26.34	30.33	28.48	28.77	24.03	21.77	15.38	13.41	14.26	13.73	11.42	9.25	7.35	5.21	5.28
Total Debt/Equity (%)	92.53	111.36	120.74	104.19	129.36	165.06	121.77	131.55	155.52	191.19	144.59	154.64	184.34	211.19	253.33
Total Debt/Capital (%)	48.06	52.69	54.7	51.03	56.4	62.27	54.91	56.81	60.86	65.66	59.12	60.73	64.83	67.86	71.7
Total Debt/Total Assets (%)	47.13	51.68	53.59	49.7	55.03	60.17	52.33	54.01	57.82	61.54	56.86	58.31	62.11	65.28	68.34
Net Debt to Equity	86.37	109.64	118.73	102.3	127.36	163	120.17	129.02	147.24	181.98	130.14	146.32	174.81	201.15	241.46
Net Debt/Capital (%)	46.34	52.3	54.28	50.57	56.02	61.98	54.58	56.34	58.39	63.28	55.37	58.22	62.37	65.47	69.2
EBITDA	22	37	38	40	43	46	49	51	51	51	56	57	59	64	63
EBITDA-CapEx	-18	20	33	25	26	-15	40	47	46	49	43	43	51	64	63
Operating Income (Loss)	15	17	19	19	21	23	24	27	26	26	29	31	31	37	35

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.14	0.03	0.03	0.04	0.03	0.02	0.02	0.02	0.03	0.02	0.08	0.02	0.02	0.02	0.02
Current Ratio	0.19	0.09	0.09	0.1	0.07	0.05	0.06	0.07	0.07	0.06	0.41	0.34	0.31	0.29	0.28
Quick Ratio	0.19	0.09	0.09	0.1	0.07	0.05	0.06	0.07	0.07	0.06	0.41	0.34	0.31	0.29	0.28
CFO/Avg Current Liab	0.5	0.36	0.34	0.33	0.31	0.22	0.23	0.21	0.2	0.18	0.18	0.16	0.13	0.13	0.13
Common Equity/Total Assets	50.92	46.38	44.39	47.7	42.54	36.45	42.97	41.06	37.18	32.19	39.32	37.71	33.69	30.91	26.98
Long-Term Debt/Equity (%)	51.7	65.37	64.17	60.32	56.48	59.71	35.79	32.67	38.35	42.65	29.05	24.52	21.8	16.86	19.58
Long-Term Debt/Capital (%)	26.85	30.93	29.07	29.54	24.62	22.53	16.14	14.11	15.01	14.65	11.88	9.63	7.67	5.42	5.54
Long-Term Debt/Total Assets (%)	26.34	30.33	28.48	28.77	24.03	21.77	15.38	13.41	14.26	13.73	11.42	9.25	7.35	5.21	5.28
Total Debt/Equity (%)	92.53	111.36	120.74	104.19	129.36	165.06	121.77	131.55	155.52	191.19	144.59	154.64	184.34	211.19	253.33
Total Debt/Capital (%)	48.06	52.69	54.7	51.03	56.4	62.27	54.91	56.81	60.86	65.66	59.12	60.73	64.83	67.86	71.7
Total Debt/Total Assets (%)	47.13	51.68	53.59	49.7	55.03	60.17	52.33	54.01	57.82	61.54	56.86	58.31	62.11	65.28	68.34
CFO/Total Liabilities	11.74	14.99	15.08	14.62	14.49	12.21	16.46	15.05	13.89	13.2	13.14	12.37	10.86	11.69	11.9
CFO/CapEx	0.53	1.75	6.69	2.1	2.28	0.67	5.09	10.59	8.35	19.51	3.67	3.44	5.64	- -	- -
Altman's Z-Score	3.45	3.75	3.42	3.59	3.21	3	3.92	3.56	4.92	3.3	3.2	2.85	2.74	2.68	2.76

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	11.92	12.18	10.66	10.25	10.06	9.57	8.66	7.89	7.42	7.32	7.5	7.08	6.78	6.72	6.47
Days Sales Outstanding	30.63	29.98	34.25	35.62	36.28	38.14	42.16	46.24	49.22	49.84	48.67	51.52	53.81	54.29	56.43
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	30.63	29.98	34.25	35.62	36.28	38.14	42.16	46.24	49.22	49.84	48.67	51.52	53.81	54.29	56.43
Inventory to Cash Days	30.63	29.98	34.25	35.62	36.28	38.14	42.16	46.24	49.22	49.84	48.67	51.52	53.81	54.29	56.43
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	494	642	515	640	666	892	1,032	844	1,615	885	820	659	598	515	544
- Cash & Cash Equivalents	12	3	3	4	4	4	3	5	6	6	23	8	8	7	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	175	198	200	213	252	316	256	261	283	304	340	354	370	379	386
Enterprise Value	657	837	712	849	915	1,204	1,285	1,100	1,891	1,183	1,138	1,006	960	887	923
Total Capital	364	376	366	418	447	507	467	460	464	463	576	583	571	559	538
Total Debt/Capital (%)	48.06	52.69	54.7	51.03	56.4	62.27	54.91	56.81	60.86	65.66	59.12	60.73	64.83	67.86	71.7
Total Debt / EV	0.27	0.24	0.28	0.25	0.28	0.26	0.2	0.24	0.15	0.26	0.3	0.35	0.39	0.43	0.42
EV/Sales	22.29	15.52	13.11	14.21	14.31	17.94	17.76	14.43	24.51	15.17	13.51	11.1	10.05	8.96	9.31
EV/EBITDA	30.01	22.47	18.93	21	21.24	26.37	26.09	21.37	36.78	23.02	20.26	17.62	16.29	13.86	14.55
EV/EBIT	45.02	49.13	37.96	43.61	43.82	53.16	53.21	41.19	73.44	45.51	39.41	32.79	30.63	24.12	26.56
EV/Cash Flow to Firm	27.65	21.72	18.36	20.63	19.72	24.03	22.91	20.91	35.56	22.55	20.12	17.47	16.04	12.54	13.15
EV/Free Cash Flow to Firm	10.27	14.91	16.38	14.96	14.48	10.9	19.73	19.42	32.44	21.62	16.36	14.13	14.23	12.54	13.15
Diluted Market Cap	493	641	509	622	665	883	1,023	842	1,614	885	819	658	597	515	544
Diluted Enterprise Value	657	836	705	832	914	1,195	1,276	1,098	1,890	1,183	1,137	1,005	960	887	923
EV per Share	51.89	65.97	55.35	63.85	68.65	88.52	93.53	80.01	137.46	85.93	82.52	72.84	69.45	64.07	66.55
TTM Sales	29	54	54	60	64	67	72	76	77	78	84	91	96	99	99
TTM EBITDA	22	37	38	40	43	46	49	51	51	51	56	57	59	64	63
TTM Operating Income	15	17	19	19	21	23	24	27	26	26	29	31	31	37	35
TTM Cash Flow to Firm	24	39	39	41	46	50	56	53	53	52	57	58	60	71	70
TTM Free Cash Flow to Firm	64	56	43	57	63	110	65	57	58	55	70	71	67	71	70

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	8.01	13.25	14.15	12.86	12.11	8.74	18.59	17.92	33.79	19.04	13.5	10.9	11.82	10.98	11.07
EV/EBIT	45.02	49.13	37.96	43.61	43.82	53.16	53.21	41.19	73.44	45.51	39.41	32.79	30.63	24.12	26.56
Enterprise Value	657	837	712	849	915	1,204	1,285	1,100	1,891	1,183	1,138	1,006	960	887	923
Low Price	32	37.5	38.36	39.5	42.81	45.42	59.11	53	59.38	52.25	55.01	40.92	37	32.27	34.56
EV/Sales	22.29	15.52	13.11	14.21	14.31	17.94	17.76	14.43	24.51	15.17	13.51	11.1	10.05	8.96	9.31
EV/EBITDA	30.01	22.47	18.93	21	21.24	26.37	26.09	21.37	36.78	23.02	20.26	17.62	16.29	13.86	14.55
Price/Earnings	6.68	32.9	38.6	12.07	28.06	51.3	22.43	34.8	84.98	45.42	7.49	31.15	38.72	26.7	30.78
Price/Earnings Average	6.57	27.68	46.01	11	27.99	44.4	21.47	37.19	65.61	58.59	7.88	34.25	41.31	28.71	30.97
Price/Earnings High	7.54	33.01	56.94	12.46	32.29	51.62	25.36	43.65	89.67	93.57	9.53	40.02	51.49	33.94	33.75
Price/Earnings Low	5.48	24.38	36.96	9.91	24.02	35.52	17.65	30.06	43	36.92	6.93	26.7	33.12	23.16	27.13
Price/Book Value	2.62	3.61	3.11	3.13	3.42	4.66	4.9	4.25	8.88	5.57	3.48	2.88	2.98	2.87	3.57
Price/Book Value Average	2.57	3.04	3.71	2.85	3.41	4.04	4.69	4.54	6.86	7.18	3.67	3.16	3.17	3.09	3.59
Price/Book Value High	2.95	3.63	4.59	3.23	3.93	4.69	5.54	5.33	9.37	11.47	4.43	3.69	3.96	3.65	3.92
Price/Book Value Low	2.15	2.68	2.98	2.57	2.93	3.23	3.86	3.67	4.5	4.53	3.22	2.47	2.55	2.49	3.15
Price/Tangible Book Value	3.07	4.24	3.56	3.53	3.8	5.33	5.43	4.66	9.66	6.01	3.64	3	3.12	2.99	3.71
Price/Tangible Book Value Average	3.02	3.57	4.24	3.21	3.79	4.61	5.2	4.98	7.46	7.75	3.83	3.3	3.33	3.22	3.73
Price/Tangible Book Value High	3.47	4.26	5.25	3.64	4.38	5.36	6.14	5.84	10.19	12.38	4.63	3.85	4.15	3.8	4.07
Price/Tangible Book Value Low	2.52	3.14	3.41	2.9	3.25	3.69	4.27	4.02	4.89	4.89	3.37	2.57	2.67	2.6	3.27
Price/Sales	16.72	11.88	9.36	10.4	10.4	13.16	14.15	11.05	20.89	11.32	9.72	7.25	6.24	5.19	5.46
Price/Sales Average	16.43	9.99	11.16	9.48	10.37	11.39	13.54	11.81	16.13	14.6	10.22	7.98	6.66	5.58	5.5
Price/Sales High	18.86	11.92	13.81	10.75	11.96	13.25	15.99	13.86	22.04	23.33	12.35	9.32	8.3	6.59	5.99
Price/Sales Low	13.72	8.8	8.97	8.54	8.9	9.12	11.13	9.54	10.57	9.2	8.99	6.22	5.34	4.5	4.82
Price/Cash Flow	23.07	20.82	16.24	18.97	17.41	21.68	22.24	19.62	37.78	19.98	17.14	14.04	13.89	10.95	11.04
Price/Cash Flow Average	22.68	17.52	19.36	17.29	17.37	18.76	21.29	20.96	29.17	25.77	18.03	15.44	14.82	11.77	11.11
Price/Cash Flow High	26.03	20.89	23.96	19.59	20.04	21.82	25.14	24.6	39.87	41.16	21.8	18.04	18.47	13.92	12.11
Price/Cash Flow Low	18.93	15.42	15.55	15.57	14.91	15.01	17.51	16.94	19.12	16.24	15.86	12.04	11.88	9.49	9.73
Price/Free Cash Flow Average	7.87	11.15	16.86	11.72	12.08	7.56	17.79	19.15	26.09	24.55	14.2	11.98	12.61	11.8	11.14
Price/Free Cash Flow High	9.04	13.3	20.87	13.28	13.93	8.79	21.01	22.48	35.66	39.22	17.16	14	15.72	13.95	12.14
Price/Free Cash Flow Low	6.57	9.82	13.55	10.56	10.36	6.05	14.63	15.48	17.1	15.48	12.48	9.34	10.11	9.52	9.76
EV/Sales Average	22	13.63	14.93	13.26	14.28	16.16	17.14	15.19	19.74	18.46	14.02	11.82	10.46	9.35	9.34
EV/Sales High	24.43	15.56	17.62	14.56	15.88	18.03	19.62	17.25	25.66	27.2	16.15	13.17	12.11	10.37	9.84
EV/Sales Low	19.28	12.43	12.71	12.29	12.81	13.86	14.72	12.92	14.17	13.05	12.78	10.06	9.14	8.27	8.66
EV/EBITDA Average	29.62	19.74	21.56	19.6	21.2	23.74	25.19	22.49	29.62	28.01	21.02	18.77	16.97	14.46	14.61
EV/EBITDA High	32.89	22.53	25.44	21.52	23.57	26.49	28.82	25.54	38.51	41.28	24.22	20.9	19.64	16.04	15.38
EV/EBITDA Low	25.96	18.01	18.35	18.16	19.01	20.36	21.63	19.13	21.27	19.8	19.16	15.97	14.82	12.79	13.54
EV/EBIT Average	44.44	43.15	43.24	40.7	43.74	47.87	51.37	43.35	59.15	55.37	40.89	34.93	31.9	25.17	26.66
EV/EBIT High	49.35	49.26	51.01	44.69	48.63	53.41	58.78	49.22	76.9	81.59	47.12	38.91	36.92	27.92	28.07
EV/EBIT Low	38.95	39.37	36.8	37.73	39.22	41.05	44.11	36.88	42.46	39.14	37.28	29.72	27.87	22.26	24.71
Last Price	39	50.61	40.06	48.12	50.01	65.59	75.11	61.37	117.36	64.27	59.47	47.73	43.25	37.21	39.21
High Price	43.99	50.78	59.09	49.7	57.55	66	84.9	76.97	123.84	132.41	75.61	61.32	57.52	47.3	43
Enterprise Value Average	649	735	811	793	913	1,084	1,240	1,158	1,523	1,440	1,180	1,071	1,000	926	927
Enterprise Value High	720	839	956	870	1,015	1,209	1,419	1,314	1,980	2,122	1,360	1,193	1,157	1,027	976
Enterprise Value Low	569	671	690	735	819	929	1,065	985	1,093	1,018	1,076	912	874	819	859

Shares Outstanding	13	13	13	13	13	14	14	14	14	14	14	14	14	14	14
Diluted Weighted Avg Shares	13	13	13	13	13	13	14	14	14	14	14	14	14	14	14
Basic Weighted Avg Shares	13	13	13	13	13	13	14	14	14	14	14	14	14	14	14
Revenue per Share	2.33	4.26	4.28	4.62	4.81	4.98	5.31	5.55	5.62	5.68	6.12	6.58	6.93	7.17	7.18
EBITDA per Share	1.73	2.94	2.96	3.13	3.24	3.39	3.61	3.75	3.74	3.74	4.08	4.14	4.28	4.64	4.59
Operating Income per Share	1.15	1.35	1.48	1.51	1.57	1.68	1.77	1.95	1.88	1.89	2.1	2.23	2.27	2.67	2.52
Basic EPS, GAAP	5.84	1.54	1.04	3.99	1.78	1.28	3.35	1.76	1.38	1.42	7.94	1.53	1.12	1.39	1.27
Basic EPS from Cont Ops	5.84	1.54	1.04	3.99	1.78	1.28	3.35	1.76	1.38	1.42	7.94	1.53	1.12	1.39	1.27
Diluted EPS, GAAP	5.83	1.54	1.04	3.99	1.78	1.28	3.35	1.76	1.38	1.41	7.92	1.53	1.11	1.39	1.27
Diluted EPS from Cont Ops	5.83	1.54	1.04	3.99	1.78	1.28	3.35	1.76	1.38	1.41	7.92	1.53	1.11	1.39	1.27
Dividend per Share	2.43	2.46	2.5	2.53	2.56	2.61	2.65	2.68	2.72	2.76	2.8	2.84	2.88	2.93	2.97
Cash Flow per Share	1.69	2.43	2.47	2.54	2.87	3.03	3.38	3.13	3.11	3.22	3.47	3.4	3.11	3.4	3.55
Free Cash Flow per Basic Share	-1.49	1.04	2.1	1.33	1.61	-1.46	2.71	2.83	2.73	3.05	2.52	2.41	2.56	3.4	3.55
Cash & Equivalents per Share	0.92	0.24	0.26	0.29	0.29	0.29	0.25	0.37	0.44	0.42	1.63	0.55	0.59	0.51	0.48
Book Value per Share	14.91	14	12.88	15.38	14.64	14.07	15.33	14.45	13.21	11.55	17.07	16.6	14.54	12.96	10.98
Tangible Book Value per Share	12.69	11.93	11.26	13.64	13.15	12.31	13.83	13.18	12.15	10.69	16.35	15.91	13.88	12.43	10.58

Universal Health Realty Income Trust

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)